Literature DB >> 7566090

Induction of apoptosis in mature T cells by tumour necrosis factor.

L Zheng1, G Fisher, R E Miller, J Peschon, D H Lynch, M J Lenardo.   

Abstract

T-cell receptor-induced apoptosis regulates immune responses and can result from interactions between Fas (Apo1/CD95) and Fas ligand (FasL). Mutations in the genes for Fas and FasL cause disorders resembling human autoimmune diseases in lpr and gld mice, respectively. However, peripheral T-cell deletion takes place in lpr mice, and autoimmune syndromes occur in mouse strains without Fas or FasL defects. Here we show that tumour necrosis factor (TNF) can mediate mature T-cell receptor-induced apoptosis through the p75 TNF receptor. Blockage of both TNF and FasL is required to abrogate T-cell death and TNF mediates the death of most CD8+ T cells, whereas FasL mediates the death of most CD4+ T cells. Our results suggest that autoregulatory apoptosis of the mature T cells can occur by two distinct molecular mechanisms.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7566090     DOI: 10.1038/377348a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  261 in total

1.  T cell receptor-induced activation and apoptosis in cycling human T cells occur throughout the cell cycle.

Authors:  M Karas; T Z Zaks; J L Liu; D LeRoith
Journal:  Mol Biol Cell       Date:  1999-12       Impact factor: 4.138

Review 2.  Specificity, restriction and effector mechanisms of immunoregulatory CD8 T cells.

Authors:  M Vukmanovic-Stejic; M J Thomas; A Noble; D M Kemeny
Journal:  Immunology       Date:  2001-02       Impact factor: 7.397

3.  Inhibition of apoptosis by ionomycin and zinc in peripheral blood mononuclear cells (PBMC) of leprosy patients.

Authors:  A Gupta; V K Sharma; H Vohra; N K Ganguly
Journal:  Clin Exp Immunol       Date:  1999-07       Impact factor: 4.330

4.  Apoptosis: A Current Molecular Analysis.

Authors:  Dean G Tang; Arthur T Porter
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

5.  Bladder cancer immunogenicity: expression of CD80 and CD86 is insufficient to allow primary CD4+ T cell activation in vitro.

Authors:  S J Pettit; S Ali; E O'Flaherty; T R Griffiths; D E Neal; J A Kirby
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

6.  CD8(+) T-cell selection, function, and death in the primary immune response in vivo.

Authors:  M F Callan; C Fazou; H Yang; T Rostron; K Poon; C Hatton; A J McMichael
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

Review 7.  Molecular steps of cell suicide: an insight into immune senescence.

Authors:  S Gupta
Journal:  J Clin Immunol       Date:  2000-07       Impact factor: 8.317

8.  Enhanced T cell apoptosis in common variable immunodeficiency: negative role of the fas/fasligand system and of the Bcl-2 family proteins and possible role of TNF-RS.

Authors:  M Di Renzo; D Serrano; Z Zhou; I George; K Becker; C Cunningham-Rundles
Journal:  Clin Exp Immunol       Date:  2001-07       Impact factor: 4.330

9.  Acetylation of GATA-3 affects T-cell survival and homing to secondary lymphoid organs.

Authors:  T Yamagata; K Mitani; H Oda; T Suzuki; H Honda; T Asai; K Maki; T Nakamoto; H Hirai
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

10.  Systemic autoimmunity and defective Fas ligand secretion in the absence of the Wiskott-Aldrich syndrome protein.

Authors:  Nikolay P Nikolov; Masaki Shimizu; Sophia Cleland; Daniel Bailey; Joseph Aoki; Ted Strom; Pamela L Schwartzberg; Fabio Candotti; Richard M Siegel
Journal:  Blood       Date:  2010-05-10       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.